Paushak Limited has announced the commencement of commercial production at its new multi-purpose manufacturing facility, marking a significant milestone in the company's expansion strategy. The facility represents a substantial investment of ₹175 crore, demonstrating the company's commitment to enhancing its manufacturing capabilities.

Investment and Facility Details

The new multi-purpose plant showcases PaushaK Limited's strategic focus on diversifying its production capabilities. The following table summarizes the key investment parameters:

Production Timeline and Strategy

The company has adopted a phased approach for the rollout of operations at the new facility. This strategic implementation is expected to unfold over the next year, allowing for systematic scaling of production capabilities. The phased rollout strategy indicates a measured approach to optimizing operations and ensuring quality standards are maintained throughout the expansion process.

Manufacturing Capabilities Enhancement

The multi-purpose nature of the new plant positions PaushaK Limited to diversify its production portfolio and respond more effectively to market demands. This facility expansion represents a significant step in the company's growth trajectory, potentially enabling the production of various products under one roof. The substantial investment of ₹175 crore underscores the company's confidence in its long-term growth prospects and market opportunities.

The commencement of commercial production at this new facility marks an important development for PaushaK Limited, as it enhances the company's overall manufacturing capacity and operational flexibility. The planned phased implementation over the coming year suggests a systematic approach to maximizing the facility's potential while maintaining operational efficiency.

Paushak Limited has announced that CRISIL Ratings Limited has reaffirmed its long-term credit rating and assigned short-term credit ratings for the company's enhanced bank loan facilities. The rating agency communicated this decision through a letter dated January 15, 2026, marking a significant expansion in the company's credit facilities.

Enhanced Credit Facilities Overview

The total bank loan facilities rated by CRISIL have been substantially enhanced to ₹145 crores, representing a significant increase from the previous limit of ₹40 crores. This enhancement reflects the company's growing financial requirements and CRISIL's confidence in Paushak's creditworthiness.

Detailed Rating Structure

CRISIL has provided comprehensive ratings across multiple facility types for Paushak Limited:

Rating Categories Explained

The rating structure includes both long-term and short-term credit assessments. CRISIL has reaffirmed the long-term credit rating at A/Stable for the term loan facility worth ₹70 crores. For short-term facilities, the rating agency has assigned CRISIL A1 ratings to three working capital facilities totaling ₹75 crores, including a proposed facility of ₹30 crores and existing facilities of ₹20 crores and ₹25 crores respectively.

Regulatory Compliance

Paushak Limited has disclosed this credit rating information in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed both BSE Limited and National Stock Exchange of India Limited about the rating reaffirmation and assignment through official communications.

Company Background

Paushak Limited operates in the chemicals sector and maintains its registered office at Alembic Road, Vadodara, Gujarat. The company holds multiple ISO certifications including ISO 9001, ISO 14001, and ISO 45001, demonstrating its commitment to quality, environmental management, and occupational health and safety standards.